Encompass Health Corp
EHC104.848USD
-1.102-1.04%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
10.55BCap. mercado
19.52P/E TTM
Más Datos de Encompass Health Corp Compañía
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Información de Encompass Health Corp
Símbolo de cotizaciónEHC
Nombre de la empresaEncompass Health Corp
Fecha de salida a bolsaSep 24, 1986
Director ejecutivoTarr (Mark J)
Número de empleados23564
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 24
Dirección9001 Liberty Pkwy
CiudadBIRMINGHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal35242-7509
Teléfono12059677116
Sitio Webhttps://www.encompasshealth.com/
Símbolo de cotizaciónEHC
Fecha de salida a bolsaSep 24, 1986
Director ejecutivoTarr (Mark J)
Ejecutivos de Encompass Health Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Douglas E. (Doug) Coltharp
Mr. Douglas E. (Doug) Coltharp
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
251.19K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3.71%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.75K
+0.15%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.22K
+0.16%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-5.13%
Mr. Gregory D. (Greg) Carmichael
Mr. Gregory D. (Greg) Carmichael
Independent Director
Independent Director
18.63K
+0.12%
Mr. Terrance Williams
Mr. Terrance Williams
Independent Director
Independent Director
15.14K
+0.15%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Independent Director
Independent Director
15.09K
+2.06%
Dr. Elissa Joy Charbonneau
Dr. Elissa Joy Charbonneau
Chief Medical Officer
Chief Medical Officer
11.96K
-26.35%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Douglas E. (Doug) Coltharp
Mr. Douglas E. (Doug) Coltharp
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
251.19K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3.71%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.75K
+0.15%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.22K
+0.16%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-5.13%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Medicare
939.70M
64.46%
Medicare Advantage
246.00M
16.88%
Managed Care
163.00M
11.18%
Medicaid
45.20M
3.10%
Other Income Source
41.30M
2.83%
Otro
22.50M
1.54%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Medicare
939.70M
64.46%
Medicare Advantage
246.00M
16.88%
Managed Care
163.00M
11.18%
Medicaid
45.20M
3.10%
Other Income Source
41.30M
2.83%
Otro
22.50M
1.54%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Otro
70.16%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Otro
70.16%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
49.19%
Investment Advisor/Hedge Fund
34.64%
Hedge Fund
6.41%
Bank and Trust
2.15%
Pension Fund
2.06%
Research Firm
1.80%
Individual Investor
1.50%
Sovereign Wealth Fund
1.24%
Insurance Company
0.13%
Otro
0.88%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1064
98.33M
97.73%
-1.53M
2025Q3
1072
97.93M
99.39%
+709.65K
2025Q2
1033
97.25M
101.81%
-1.92M
2025Q1
979
99.67M
102.60%
-3.66M
2024Q4
945
99.00M
102.85%
-881.71K
2024Q3
884
99.36M
106.17%
-310.63K
2024Q2
889
99.51M
109.15%
-995.73K
2024Q1
858
100.71M
112.68%
-12.13M
2023Q4
852
101.16M
110.27%
+2.80M
2023Q3
865
97.95M
111.77%
+322.90K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
10.22M
10.15%
-140.47K
-1.36%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.48M
8.43%
-4.83K
-0.06%
Sep 30, 2025
Invesco Advisers, Inc.
4.48M
4.45%
-276.20K
-5.81%
Sep 30, 2025
T. Rowe Price Associates, Inc.
3.77M
3.74%
+2.44M
+184.81%
Sep 30, 2025
State Street Investment Management (US)
3.08M
3.06%
-24.31K
-0.78%
Sep 30, 2025
Wellington Management Company, LLP
2.78M
2.76%
-744.16K
-21.11%
Sep 30, 2025
AllianceBernstein L.P.
2.52M
2.5%
+476.56K
+23.37%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.14M
2.13%
-34.67K
-1.59%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
2.06M
2.05%
+238.21K
+13.06%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.81M
1.8%
+34.70K
+1.96%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
PGIM Jennison Focused Mid-Cap ETF
3.17%
Inspire Growth ETF
2.88%
Opus Small Cap Value ETF
2.23%
State Street SPDR S&P Health Care Services ETF
1.86%
iShares U.S. Healthcare Providers ETF
1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
1.74%
Bahl & Gaynor Dividend ETF
1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
JPMorgan Active Small Cap Value ETF
1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
1.07%
Ver más
PGIM Jennison Focused Mid-Cap ETF
Proporción3.17%
Inspire Growth ETF
Proporción2.88%
Opus Small Cap Value ETF
Proporción2.23%
State Street SPDR S&P Health Care Services ETF
Proporción1.86%
iShares U.S. Healthcare Providers ETF
Proporción1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
Proporción1.74%
Bahl & Gaynor Dividend ETF
Proporción1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción1.18%
JPMorgan Active Small Cap Value ETF
Proporción1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proporción1.07%
Dividendos
Un total de
334.60M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Oct 23, 2025
EHC.NB Final Cash Dividend of gross USD 0.19 paid on Jan 15, 2026 going ex on Jan 02, 2026
Jan 02, 2026
Jan 15, 2026
Jan 02, 2026
Jul 24, 2025
EHC.NB Interim Cash Dividend of gross USD 0.19 paid on Oct 15, 2025 going ex on Oct 01, 2025
Oct 01, 2025
Oct 15, 2025
Oct 01, 2025
May 01, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 15, 2025 going ex on Jul 01, 2025
Jul 01, 2025
Jul 15, 2025
Jul 01, 2025
Feb 20, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 15, 2025 going ex on Apr 01, 2025
Apr 01, 2025
Apr 15, 2025
Apr 01, 2025
Oct 17, 2024
EHC.NB Final Cash Dividend of gross USD 0.17 paid on Jan 15, 2025 going ex on Jan 02, 2025
Jan 02, 2025
Jan 15, 2025
Jan 02, 2025
Jul 24, 2024
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 15, 2024 going ex on Oct 01, 2024
Oct 01, 2024
Oct 15, 2024
Oct 01, 2024
May 02, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Jul 15, 2024 going ex on Jul 01, 2024
Jul 01, 2024
Jul 15, 2024
Jul 01, 2024
Feb 28, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Apr 15, 2024 going ex on Mar 28, 2024
Apr 01, 2024
Apr 15, 2024
Mar 28, 2024
Oct 19, 2023
EHC.NB Final Cash Dividend of gross USD 0.15 paid on Jan 16, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 16, 2024
Dec 29, 2023
Jul 20, 2023
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Oct 16, 2023 going ex on Sep 29, 2023
Oct 02, 2023
Oct 16, 2023
Sep 29, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Encompass Health Corp?
Los cinco principales accionistas de Encompass Health Corp son:
The Vanguard Group, Inc. posee 10.22M acciones, lo que representa el 10.15% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 8.48M acciones, lo que representa el 8.43% del total de acciones.
Invesco Advisers, Inc. posee 4.48M acciones, lo que representa el 4.45% del total de acciones.
T. Rowe Price Associates, Inc. posee 3.77M acciones, lo que representa el 3.74% del total de acciones.
State Street Investment Management (US) posee 3.08M acciones, lo que representa el 3.06% del total de acciones.
The Vanguard Group, Inc. posee 10.22M acciones, lo que representa el 10.15% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 8.48M acciones, lo que representa el 8.43% del total de acciones.
Invesco Advisers, Inc. posee 4.48M acciones, lo que representa el 4.45% del total de acciones.
T. Rowe Price Associates, Inc. posee 3.77M acciones, lo que representa el 3.74% del total de acciones.
State Street Investment Management (US) posee 3.08M acciones, lo que representa el 3.06% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Encompass Health Corp?
Los tres principales tipos de accionista de Encompass Health Corp son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Invesco Advisers, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Invesco Advisers, Inc.
¿Cuántas instituciones poseen acciones de Encompass Health Corp (EHC)?
A fecha de 2025Q4, 1064 instituciones poseen acciones de Encompass Health Corp, con un valor de mercado combinado de aproximadamente 98.33M, lo que representa el 97.73% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -1.67%.
¿Cuál es la mayor fuente de ganancias de Encompass Health Corp?
El FY2025Q2, el segmento empresarial Medicare generó la ganancia más alta para Encompass Health Corp, ascendiendo a 939.70M y representando el 64.46% de la ganancia total.
